Petauri, a rapidly expanding pharmaceutical services platform, proudly announces the appointment of Megan Jankura and Liz Lucas as co-leaders of Petauri MAx, effective immediately. This strategic move is expected to greatly enhance the firm's capacity to deliver innovative market access solutions tailored for its pharmaceutical and biotech partners. Reporting to Dan Vanderpoel, the Managing Partner of Petauri MAx and Head of Client Partnerships, both Jankura and Lucas bring a wealth of experience and proven track records that align with the company’s growth ambitions.
Megan Jankura joins the Petauri MAx team with nearly 20 years of expertise in strategic leadership within market access and business development. Acclaimed for her exceptional ability to develop actionable strategies that effectively convert data into significant results, Jankura has played a pivotal role in pioneering innovations that enhance business processes. Dan Vanderpoel remarked, "Megan's impressive background in client partnerships, combined with her deep understanding of market access, positions her as an essential asset to our leadership team." Previously, she collaborated closely with Vanderpoel at Precision Value Health, navigating intricate payer landscapes for a diverse array of clients.
Liz Lucas is no stranger to the Petauri family; she has dedicated over 20 years to market access and has been a vital part of the organization. Currently serving as Executive Vice President of Client Services, she has been influential in nurturing teamwork, fostering collaboration, and devising scalable solutions in nuanced market environments. Her strong client relationships and proficiency in payer engagement strategies make her a key contributor in advancing the client-first mission of Petauri MAx. Sarah McNulty, Group President, stated, "Liz’s leadership combined with her extensive industry insights have been integral in crafting innovative go-to-market strategies that resonate with clients."
The complementary strengths brought by Jankura and Lucas are expected to redefine the trajectory of Petauri MAx, as they aim to expand its market access offerings focusing on strategic payer marketing solutions. Vanderpoel expressed confidence in their collaborative efforts, emphasizing, "Together, Megan and Liz's commitment to excellence will certainly ensure Petauri MAx continues to excel in innovation and client satisfaction."
Founded in Nashville, Tennessee, by CEO Dan Renick in partnership with Oak Hill Capital, Petauri operates as a dedicated pharmaceutical services platform. Since its inception in 2023, it has experienced remarkable growth, launching multiple agencies such as Petauri Advisors and acquiring firms like The Kinetix Group. The significant backing from Oak Hill, which plans to invest upwards of $250 million into this initiative, showcases the ambitious growth strategy, as the platform focuses on improving patient outcomes by establishing the value of medical advancements.
The focus of Petauri extends beyond traditional pharmaceutical services, aiming to create scientific, economic, and societal value through innovative strategies and solutions. By actively supporting their clients from strategy formulation to comprehensive implementation processes, Petauri manifests its commitment to excellence and to facilitate faster patient access to transformative healthcare.
For further information about Petauri and to explore their wide array of services, please visit
Petauri's website.